Conditions: Metabolic Syndrome
Keywords: Metabolic syndrome,dyslipidemia,fluvastatin extended release
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 614
Healthy volunteers: no

Brief summary:
This study evaluated safety, tolerability and efficacy of Fluvastatin XL® -extended release (80 mg once daily) in patients with metabolic syndrome

Detailed description:

Arms:
arm 1: 80 mg once daily, at bedtime.

Interventions: intervention 1: Fluvastatin XL®
Intervention descriptions: intervention 1: Fluvastatin extended release 80 mg

Protocol document: